Good MorningEquity markets advanced for the 6th consecutive week, setting new all-time highs each week. The S&P 500 is in a solid rally driven by earnings and an outlook for FOMC leniency, and it may accelerate. This week's round of economic data includes reads on inflation, housing, and consumer spending that could invigorate bulls, but there are risks.
Among the risks are hot data and cold data. Hot data will keep the FOMC policy tight, while cold data will do the opposite. The caveat is that cold data would suggest the onset of the recession lurking around the corner for the last two years. Looking at the S&P 500 market from the valuation perspective, the S&P 500 is overbought and trending above its long-term average P/E ratios, set up for a fall. Looking at it from the technical perspective, the index broke out of a trading range to new highs in January and could advance another 20% to 30% before it hits the final peak. Featured: Elon Musk's "Project Dojo" is a Game-Changer (Stansberry Research) |
Markets | |
The stock market is about to go on a new tear. Some may call it a continuation of an existing trend. Others may consider it an explosive turnaround. Where do the indices get room to make a turnaround after the S&P 500 and NASDAQ hit a new all-time high? Well, the truth is that not all stocks a... Read the Full Story |
|
From Our Partners—but also hand Joe Biden a landslide re-election win. What would America look like if we slide further towards Socialism? Full story and 4 steps you can take, | | detailed here… |
|
Markets | |
Earnings season has kicked off, and markets are more tuned into the potential money shifts coming to the economy in this new cycle. One of the most eagerly awaited shifts is the proposed interest rate cuts coming from the FED this year. With that in mind, it Is more important than ever to make sur... Read the Full Story |
|
Markets | |
Tradeweb Markets Inc. (NASDAQ: TW) is a global developer and operator of electronic marketplaces, notably for bonds, ETFs, and derivatives. It's grown to become one of the leading electronic marketplaces for fixed-income trading. Traditionally, bond markets have been open outcry and specialist-run... Read the Full Story |
|
From Our PartnersThanks to this brand-new institutional-grade trading tool…
You can now identify the #1 strongest stock in the S&P 500…
And the #1 weakest stock in the S&P 500….
On any time frame… With the click of a mouse! | | Click here to see if there are any spots left! |
|
Markets | | Asian shares mostly rose Tuesday, as investors watched for the latest indicators on U.S. inflation. Japan's benchmark Nikkei 225 added 2.2% in morning trading to 37,723.62. Australia's S&P/ASX 200 edged up nearly 0.1% to 7,619.20. South Korea's Kospi jumped 1.2% to 2,651.33. Trading was closed i... Read the Full Story |
|
Markets | |
Leading rideshare and delivery platform operator Uber Technologies Inc. (NYSE: UBER) reported a stellar earnings report to round out its first profitable year of operations in 14 years. Uber has achieved its goal of disrupting the transportation sector while fulfilling its path to profitability. W... Read the Full Story |
|
From Our PartnersA multimillionaire stock trader's research explains how focusing on just one ticker every week has generated payouts up to a rare 2,614% in under 11 days...AND he's brought proof to show the world! | | See The Proof Here |
|
Stocks | |
Love is in the air and dollar bills are flying everywhere. And that's not just the latest catchy country song lyric.
Americans will spend a record $14.2 billion on Valentine's Day cards and gifts this year. That's according to a recent survey conducted by the National Retail Federation (NRF) and ... Read the Full Story |
|
Markets | | Diamondback Energy will attempt to buy rival Endeavor Energy Resources to create an energy giant in the Southwestern United States worth more than $50 billion. Growing confidence in an economic recovery, particularly in the U.S., has driven massive deals in the energy sector in recent months, includ... Read the Full Story |
|
Markets | | Count the rings of the gnarled olive trees dotting Mohammed Mousa’s land in the West Bank village of Nilin: They've been here centuries, far before the Palestinian family's livelihood came to depend on the whims of Israeli occupation.When Israel established a checkpoint near the Mousas' land a decad... Read the Full Story |
|
Markets | | Israel's finance minister on Sunday slammed the decision by financial ratings agency Moody’s to downgrade Israel’s credit rating, saying the announcement is a “political manifesto” that “did not include serious economic claims.” Moody’s dropped the rating on Israel’s debt on Friday, warning that the... Read the Full Story |
|
Markets | | Just a quarter of business economists and analysts expect the United States to fall into recession this year. And any downturn would likely result from an external shock — such as a conflict involving China — rather than from domestic economic factors such as higher interest rates.But respondents to... Read the Full Story |
|
Monday's Early Bird Stock Of The Day Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky. | Should I Buy Humana Stock? HUM Bull and Bear Case Explained
These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Humana was last updated on Monday, January 20, 2025 at 12:14 AM.
Humana Bull Case-
Humana Inc. reported a strong earnings per share (EPS) of $4.16 for the latest quarter, significantly exceeding analysts' expectations of $3.48. This indicates robust financial performance and potential for future growth.
-
The company has a solid return on equity of 13.20%, which suggests effective management and profitability in generating returns for shareholders.
-
Humana Inc. has announced a quarterly dividend of $0.885, translating to an annualized dividend of $3.54 and a yield of 1.25%. This provides a steady income stream for investors.
-
Recent analyst ratings show a consensus target price of $302.70, indicating potential upside from the current stock price of $255.55, which could attract investors looking for growth opportunities.
-
With a market capitalization of $30.77 billion and a relatively low debt-to-equity ratio of 0.67, Humana Inc. demonstrates financial stability, making it a potentially safer investment choice.
Humana Bear Case-
Analysts have recently cut their price targets for Humana Inc., with Wells Fargo reducing it from $387.00 to $290.00, which may indicate a lack of confidence in the stock's short-term performance.
-
The stock has experienced significant volatility, with a twelve-month high of $527.18 and a low of $213.31, suggesting that it may be subject to large price swings that could deter risk-averse investors.
-
Humana Inc. has a net margin of only 1.18%, which is relatively low and may raise concerns about the company's ability to maintain profitability in a competitive market.
-
Recent insider selling, including a notable transaction where an insider sold 3,703 shares, could signal a lack of confidence from those within the company, potentially impacting investor sentiment.
-
With a price-to-earnings (P/E) ratio of 22.64, the stock may be considered overvalued compared to industry peers, which could lead to a correction in the stock price.
| View Today's Stock Pick |
|